In GO-BEFORE and GO-FORWARD , patients received placebo + MTX , golimumab 50 mg + MTX , or golimumab 100 mg + / - MTX at baseline and every 4 weeks ; in the other 3 trials , patients received placebo or golimumab 50 or 100 mg .